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Summary Neointimal proliferation after sirolimus-eluting stent (SES) implantation
is generally inhibited by the pharmacological effects of sirolimus in comparison to
bare metal stent (BMS). Neointimal hyperplasia after BMS implantation is mainly
composed of vascular smooth muscle cells, and is usually observed as a white mass
by angioscopy and as a layer of uniform signal intensity without attenuation on
optical coherence tomography (OCT). In this case, angioscopic color of the neointima
covering the SES was obviously yellow and OCT signal patterns of the neointima
showed rapid attenuation similar to lipid tissues in atherosclerotic lesions. These
ﬁndings suggest that neointima within the SES is quite different from that of the
BMS and may contain atherosclerotic components.
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ntroduction
lthough neointimal growth inside the stent is
een as angiographic lumen loss, information on
he neointimal characteristics is not available from
oronary angiograms. Angioscopy provides direct
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isualization of the lumen and macroscopic diagno-
is for intravascular structures. Optical coherence
omography (OCT) is also capable of tissue charac-
erization on the basis of its signal patterns [1,2].
eointimal hyperplasia, recognized as a white mass
y angioscopy and as a rather thick layer of uni-
orm signals without their attenuation by OCT
3,4], covers fully over the bare metal stent (BMS)
ithin several months following its implantation
Fig. 1).
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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Figure 1 Typical ﬁndings of angioscopy, and optical coherence tomography after bare metal stent (BMS) implantation.
(A) A 43-year-old man with stable angina pectoris received implantation of a BMS (3.5mm× 13mm) in the left anterior
descending artery. Six-month follow-up angiogram shows no in-stent restenosis (arrow). (B) Angioscopy shows white
he s
ptica
l
N
fneointima covers completely over the BMS (arrow) and t
strong signals are identiﬁed by cross-sectional image of o
uniform signals without their attenuation (arrowheads).
Case report
A 64-year-old man with stable angina pec-
toris underwent successful percutaneous coronary
intervention. Three overlapping sirolimus-eluting
stents (SESs) (3.5mm× 18mm, 3.5mm× 23mm,
and 3.0mm× 23mm) were deployed for a diffuse
a
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Figure 2 Novel ﬁndings of angioscopy and optical coherence
tation. (A) Three SESs were deployed in the left anterior desc
in-stent restenosis (arrows). (B) Angioscopy shows yellow neo
struts are uncovered in the proximal overlapping segment. (C)
inside the struts of inner stent is partially recognized by optim
with their rapid attenuation similar to a lipid plaque (arrow
those of outer stent are not visible owing to backscattering otruts are invisible. (C) Circumferential stent struts with
l coherence tomography. Neointima inside the struts has
ong lesion in the left anterior descending artery.
o in-stent restenosis within the SES segment was
ound on 6-month follow-up angiograms. Coronary
ngioscopy showed localized yellow neointima cov-
red over the struts of the SES in the proximal
verlapping segment. OCT images demonstrated
hat thin membrane inside the struts of this
tomography after sirolimus-eluting stents (SESs) implan-
ending artery. Six-month follow-up angiogram shows no
intima covers over the SES (arrow), whereas some of the
In this overlapping segment, thin membranous structure
al coherence tomography. Neointima has strong signals
heads). Although struts of inner stent are clearly seen,
f the neointima.
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[ovel neointimal formation over SES
egment had high signal spots on the surface accom-
anying their rapid attenuation (Fig. 2).
iscussion
lthough there are several reports on the progress
n neointimal coverage after SES implantation
3—5], characteristics of the neointima have been
ittle known. In the present case, appearance of the
eointima over the SES was quite different from
sual neointima inside the conventional BMS. The
eointima had yellow color on the basis of angio-
copic observation. Despite the fact that our OCT
mage quality was inadequate for circumferential
valuation of the coronary lumen because of non-
entered image wire position [6], OCT pattern of
he neointima clearly showed superﬁcially strong
ignals with backscattering. According to estab-
ished criteria for the coronary plaques based on
ngioscopic and OCT ﬁndings [1,2], characteristics
f the neointima were consistent with a lipid tissue.
revious pathological examinations revealed that
rug-eluting stent implantation-induced inﬂamma-
ory responses, such as inﬁltration of several kinds
f inﬂammatory cells, giant cells, T-lymphocytes,
eutrophils, and macrophages around the struts
7—9]. Inﬁltrated macrophages in lipid-rich plaques
n vivo are identiﬁed as high signal spots by OCT
ike this case [10]. The novel neointimal prolif-
ration was found locally in the overlapping SES
egment in this case. The expression of tissue fac-
ors included in advanced atherosclerotic plaques
s enhanced by sirolimus [7,11]. In the overlap-
ing segment, therefore, double layers of polymer
nd/or drug may evoke excessive inﬂammation and
xpression of tissue factors as an experimental
tudy indicated [8]. To date, atherosclerosis is con-
idered to be an inﬂammatory disease [12]. These
nﬂammatory responses invited by SES may promote
therosclerotic changes of the tissue around stent
truts including neointima. There is no pathologi-
al conﬁrmation that lipid-like neointima based on
he characteristics of intracoronary imaging devices
ctually contains lipid tissue, because the neoin-
ima is extremely thin and is unworthy of receiving
irectional coronary atherectomy. Although the
recise mechanisms of appearance of the novel
eointima are uncertain, the above inﬂammatory
r atherosclerotic changes provoked by SES may
[
[
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ffect the lipid-like neointima similar to atheroscle-
otic tissues. Our angioscopic and OCT images
ndicate that atherosclerotic process in the neointi-
al hyperplasia inside the SES may differ from that
f the BMS.
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